SplitBio Overview

  • Founded
  • 2018
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $560K
Latest Deal Amount
  • Investors
  • 2

SplitBio General Information


Developer of single-cell genomic technologies designed to perform throughput assays without the need for custom instrumentation. The company's technologies help to analyze single-nucleus transcriptomes and take a snapshot of early postnatal development in the murine central nervous system of patients, enabling researchers to perform scalable single-cell sequencing experiments while maintaining a low doublet rate.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Primary Office
  • 4000 Mason Road
  • Suite 304
  • Seattle, WA 98195
  • United States
+1 (206) 000-0000

SplitBio Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

SplitBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 09-Sep-2019 $560K 00.00 Completed Generating Revenue
2. Grant 02-Jul-2019 00000 00.000 Completed Generating Revenue
1. Seed Round 12-Oct-2018 $1.24M $1.24M Completed Generating Revenue
To view SplitBio’s complete valuation and funding history, request access »

SplitBio Executive Team (3)

Name Title Board Seat Contact Info
Alexander Rosenberg Co-Founder, Chief Executive Officer & Board Member
Charles Roco Chief Technology Officer, Board Member & Co-Founder
Georg Friedrich Seelig Board Member & Co-Founder
To view SplitBio’s complete executive team members history, request access »

SplitBio Board Members (3)

Name Representing Role Since
Alexander Rosenberg SplitBio Co-Founder, Chief Executive Officer & Board Member 000 0000
Charles Roco SplitBio Chief Technology Officer, Board Member & Co-Founder 000 0000
Georg Friedrich Seelig SplitBio Board Member & Co-Founder 000 0000
To view SplitBio’s complete board members history, request access »

SplitBio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SplitBio Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Science Foundation Government 000 0000 000000 0
Vernon & Park Capital Venture Capital Minority 000 0000 000000 0
To view SplitBio’s complete investors history, request access »